OptimizeRx Corporation

NasdaqCM:OPRX Voorraadrapport

Marktkapitalisatie: US$94.4m

OptimizeRx Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

OptimizeRx has a total shareholder equity of $121.0M and total debt of $35.6M, which brings its debt-to-equity ratio to 29.4%. Its total assets and total liabilities are $172.9M and $51.9M respectively.

Belangrijke informatie

29.4%

Verhouding schuld/eigen vermogen

US$35.60m

Schuld

Rente dekkingsration/a
ContantUS$14.96m
AandelenUS$121.02m
Totaal verplichtingenUS$51.86m
Totaal activaUS$172.88m

Recente financiële gezondheidsupdates

OptimizeRx (NASDAQ:OPRX) Is Carrying A Fair Bit Of Debt

Jul 30
OptimizeRx (NASDAQ:OPRX) Is Carrying A Fair Bit Of Debt

Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation

Jun 24
Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation

Recent updates

OptimizeRx (NASDAQ:OPRX) Is Carrying A Fair Bit Of Debt

Jul 30
OptimizeRx (NASDAQ:OPRX) Is Carrying A Fair Bit Of Debt

OptimizeRx Corporation's (NASDAQ:OPRX) 36% Jump Shows Its Popularity With Investors

Jan 09
OptimizeRx Corporation's (NASDAQ:OPRX) 36% Jump Shows Its Popularity With Investors

Analyst Forecasts Just Became More Bearish On OptimizeRx Corporation (NASDAQ:OPRX)

Aug 24
Analyst Forecasts Just Became More Bearish On OptimizeRx Corporation (NASDAQ:OPRX)

OptimizeRx Corporation (NASDAQ:OPRX) Shares May Have Slumped 38% But Getting In Cheap Is Still Unlikely

Aug 16
OptimizeRx Corporation (NASDAQ:OPRX) Shares May Have Slumped 38% But Getting In Cheap Is Still Unlikely

Is Now An Opportune Moment To Examine OptimizeRx Corporation (NASDAQ:OPRX)?

May 31
Is Now An Opportune Moment To Examine OptimizeRx Corporation (NASDAQ:OPRX)?

OptimizeRx: A Top Candidate For My Speculative 'Bio Boom' Portfolio

Oct 12

Is Now The Time To Look At Buying OptimizeRx Corporation (NASDAQ:OPRX)?

Sep 23
Is Now The Time To Look At Buying OptimizeRx Corporation (NASDAQ:OPRX)?

OptimizeRx extends reach with Cooler Screens Partnership

Jul 26

OptimizeRx: A Small-Cap Digital Health Technology Gem With Near-Term Inflection In Profitability

Jun 27

The Strong Earnings Posted By OptimizeRx (NASDAQ:OPRX) Are A Good Indication Of The Strength Of The Business

Nov 16
The Strong Earnings Posted By OptimizeRx (NASDAQ:OPRX) Are A Good Indication Of The Strength Of The Business

Why We Think OptimizeRx Corporation's (NASDAQ:OPRX) CEO Compensation Is Not Excessive At All

Aug 13
Why We Think OptimizeRx Corporation's (NASDAQ:OPRX) CEO Compensation Is Not Excessive At All

A Look At The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)

Jul 15
A Look At The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)

Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation

Jun 24
Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation

Investors Will Want OptimizeRx's (NASDAQ:OPRX) Growth In ROCE To Persist

May 10
Investors Will Want OptimizeRx's (NASDAQ:OPRX) Growth In ROCE To Persist

Estimating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)

Mar 29
Estimating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)

Analyse van de financiële positie

Kortlopende schulden: OPRX's short term assets ($46.0M) exceed its short term liabilities ($15.0M).

Langlopende schulden: OPRX's short term assets ($46.0M) exceed its long term liabilities ($36.9M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: OPRX's net debt to equity ratio (17.1%) is considered satisfactory.

Schuld verminderen: OPRX's debt to equity ratio has increased from 0% to 29.4% over the past 5 years.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: OPRX has sufficient cash runway for more than 3 years based on its current free cash flow.

Voorspelling contante baan: OPRX has sufficient cash runway for 2.6 years if free cash flow continues to grow at historical rates of 9.9% each year.


Ontdek gezonde bedrijven